Smad1/5 cKO mice showed endometrial receptivity defects and perturbed embryo implantation, and Smad2/3 cKO mice showed endometrial disorders, sterility, and uterine cancer [55,56]. This evidence concerns the gene SMAD2 and uterine cancer.